Characteristics and prognostic implications of high-risk HPV-associated hypopharyngeal cancers

PLoS One. 2013 Nov 11;8(11):e78718. doi: 10.1371/journal.pone.0078718. eCollection 2013.

Abstract

Background: High-risk human papillomavirus (HPV) is an oncogenic virus that causes oropharyngeal cancers, and it has a favorable outcome after the treatment. Unlike in oropharyngeal cancer, the prevalence and role of high-risk HPV in the etiology of hypopharyngeal squamous cell carcinoma (HPSCC) is uncertain.

Objective: The aim of the present study was to evaluate the effect and prognostic significance of high-risk HPV in patients with HPSCC.

Methods: The study included 64 subjects with HPSCC who underwent radical surgery with or without radiation-based adjuvant therapy. Primary tumor sites were the pyriform sinus in 42 patients, posterior pharyngeal wall in 19 patients, and postcricoid area in 3 patients. High-risk HPV in situ hybridization was performed to detect HPV infection.

Results: The positive rate of high-risk HPV in situ hybridization was 10.9% (7/64). There was a significant difference in the fraction of positive high-risk HPV among pyriform sinus cancer (16.7%), posterior pharyngeal wall cancer (0%), and postcricoid area cancer (0%) (p = 0.042). The laryngoscopic examination revealed a granulomatous and exophytic appearance in 85.7% (6/7) of patients with high-risk HPV-positive pyriform sinus cancer, but in only 31.4% (11/35) of patients with high-risk HPV-negative pyriform sinus cancer (p = 0.012). Significant correlations were found between positive high-risk HPV and younger age (p = 0.050) and non-smoking status (p = 0.017). HPV-positive patients had a significantly better disease-free survival (p = 0.026) and disease-specific survival (p = 0.047) than HPV-negative patients.

Conclusions: High-risk HPV infection is significantly related to pyriform sinus cancer in patients with HPSCC.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Alphapapillomavirus / metabolism*
  • Carcinoma, Squamous Cell* / metabolism
  • Carcinoma, Squamous Cell* / mortality
  • Carcinoma, Squamous Cell* / pathology
  • Carcinoma, Squamous Cell* / therapy
  • Carcinoma, Squamous Cell* / virology
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Hypopharyngeal Neoplasms* / metabolism
  • Hypopharyngeal Neoplasms* / mortality
  • Hypopharyngeal Neoplasms* / pathology
  • Hypopharyngeal Neoplasms* / therapy
  • Hypopharyngeal Neoplasms* / virology
  • Male
  • Middle Aged
  • Papillomavirus Infections* / metabolism
  • Papillomavirus Infections* / mortality
  • Papillomavirus Infections* / pathology
  • Papillomavirus Infections* / therapy
  • Papillomavirus Infections* / virology
  • Risk Factors
  • Survival Rate

Grants and funding

No current external funding sources for this study.